Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2013; 8(12): e82137.
Published online 2013 Dec 4. doi:  10.1371/journal.pone.0082137
PMCID: PMC3852951

Development of an Automated Imaging Pipeline for the Analysis of the Zebrafish Larval Kidney

Sheng-Ping Lucinda Hwang, Editor


The analysis of kidney malformation caused by environmental influences during nephrogenesis or by hereditary nephropathies requires animal models allowing the in vivo observation of developmental processes. The zebrafish has emerged as a useful model system for the analysis of vertebrate organ development and function, and it is suitable for the identification of organotoxic or disease-modulating compounds on a larger scale. However, to fully exploit its potential in high content screening applications, dedicated protocols are required allowing the consistent visualization of inner organs such as the embryonic kidney. To this end, we developed a high content screening compatible pipeline for the automated imaging of standardized views of the developing pronephros in zebrafish larvae. Using a custom designed tool, cavities were generated in agarose coated microtiter plates allowing for accurate positioning and orientation of zebrafish larvae. This enabled the subsequent automated acquisition of stable and consistent dorsal views of pronephric kidneys. The established pipeline was applied in a pilot screen for the analysis of the impact of potentially nephrotoxic drugs on zebrafish pronephros development in the Tg(wt1b:EGFP) transgenic line in which the developing pronephros is highlighted by GFP expression. The consistent image data that was acquired allowed for quantification of gross morphological pronephric phenotypes, revealing concentration dependent effects of several compounds on nephrogenesis. In addition, applicability of the imaging pipeline was further confirmed in a morpholino based model for cilia-associated human genetic disorders associated with different intraflagellar transport genes. The developed tools and pipeline can be used to study various aspects in zebrafish kidney research, and can be readily adapted for the analysis of other organ systems.


Adverse environmental conditions and genetic influences can have a major impact on organogenesis. According to statistical surveys, 22-50% of all pregnant women take drugs within the first trimenon of gestation, often whilst they are unaware of their pregnancy [1]. However, nephrotoxic medication taken by pregnant women or administered to preterm newborns with ongoing nephrogenesis can interfere with nephron generation and thus can cause short- and potentially long-term kidney impairment [2]. Besides environmental factors, hereditary nephropathies due to mutations in genes encoding ciliary proteins are the most common cause of end-stage renal disease in children due to polycystic, cystic-dysplastic and/or nephronophthisis like renal phenotypes [3].

Despite rodent studies and observational reports in humans, detailed data on potential harmful side effects on nephrogenesis is still missing for many drugs and chemical compounds [4,5]. Additionally, there is a lack of large-scale chemical screens for modifiers of hereditary nephropathies. This is mainly due to the very laborious and time-consuming testing of substance specific effects on normal and abnormal organogenesis using standard experimental setups, thus hampering investigations on a larger scale. Additionally, in vivo imaging of kidney development in a spatiotemporal context is not feasible in rodents, necessitating animal models that are experimentally more accessible. Furthermore, dedicated imaging techniques are required which enable the in vivo visualization of developing organs and tissues on a larger scale.

The development of high content screening (HCS) technologies has had a major impact on biomedical and pharmaceutical research, as these platforms are suitable for a wide range of large-scale investigations using in vitro and in vivo model systems [6]. Due to its small size and various other experimental advantages, the zebrafish can be readily employed in large scale in vivo assays. Moreover, the high degree of anatomical and physiological homology to higher vertebrates renders it a relevant model for biomedical research [7]. Thus, the zebrafish has emerged as the main vertebrate model system for whole organism screening experiments. Consequently, the zebrafish has been successfully used in chemical, toxicological, behavioral and genetic screening experiments [4,7,8,9,1011]. Moreover, its transparency in combination with the wealth of mutant and transgenic zebrafish strains available facilitates the large scale analysis of tissue-specific phenotypes. This includes, for example, the search for anti-inflammatory, anti-angiogenic or neuroactive compounds [12,1314].

Despite its widespread usage in large scale experiments, it remains challenging to fully exploit the advantages of this model system in HCS experiments. Zebrafish embryos are largely incompatible with standard HCS protocols developed for other model systems, one of the reasons being that their relatively large size and complex three-dimensional shape often lead to random positioning and orientation of embryos within wells of microtiter plates. This especially hampers reproducibility and detailed visualization of cell or tissue morphology, as well as developmental processes. Whilst several studies and recent technological advances have tried to address these challenges, they often require sophisticated technical setups [15] or are incompatible with chemical screening [16]. Thus, there remains a demand of easy-to-use screening protocols and dedicated tools which can facilitate performing complex zebrafish HCS assays.

In the zebrafish larva, the functional pronephros comprises only 2 nephrons with fused glomeruli located ventrally to the dorsal aorta. Interestingly, despite tremendous differences in nephron number, the composition of a single nephron shows great homology at the cellular and molecular level between human and zebrafish [17,18]. Additionally, kidney development and function largely depend on the same orthologous genes for all vertebrate kidneys. Therefore, studying formation and function of the zebrafish pronephros can aid in the understanding of the role of genes mutated in kidney disease, or the impact of compounds on renal development and function in humans [17]. Thus, the combination of this in vivo model system with automated imaging technologies could serve as a tool for the large scale analysis of kidney phenotypes. However, to our current knowledge, a screening platform compatible with in vivo imaging of zebrafish larval kidneys has not been described yet.

Here, we delineate the development of an automated HCS compatible imaging pipeline designed for live imaging of zebrafish kidneys in chemical screening scenarios. Using a custom designed orientation tool, embryos could be accurately positioned in wells of microtiter plates allowing consistent imaging of dorsal views of the pronephros. Subsequent automated imaging was performed on a standard widefield screening microscope and a data handling and visualization pipeline was developed. A pilotscreen for morphological kidney abnormalities was performed using a subset of potentially nephrotoxic drugs applied to larvae of the Tg(wt1b:EGFP) transgenic line in which the developing pronephros is highlighted by GFP expression [19]. The obtained in vivo data was cross-validated by histological analysis. In addition, we demonstrate that the established microscopy platform can also be utilized for genetic disease models.

Materials and Methods

Ethics statement

All zebrafish husbandry and experimental procedures were performed in accordance with the German animal protection standards and were approved by the Government of Baden-Württemberg, Regierungspräsidium Karlsruhe, Germany (Aktenzeichen 35-9185.64).

Fish keeping and embryo handling

Adult zebrafish of the Tg(wt1b:EGFP) transgenic line [19] were maintained according to reference [20]. Eggs were collected from pairwise and batch crossings. The developmental stage of embryos was determined as previously described [21]. Embryos were raised in fish water at 28°C. At 24 hpf embryos were enzymatically dechorionated using 10 mg/ml Pronase. Embryos were transferred to a beaker, washed twice with 400 ml of fish water and transferred into clean petri dishes [22]. Prior to transferring into agarose coated microtiter plates, 48 or 72 hpf old larvae were anesthetized using 0.03% tricaine.

Drug treatment of embryos

A subset of certain drug classes was chosen for which an adverse effect on the developing kidney had been described in animal and/or human studies [2]. To evaluate concentration-dependent toxicity, 5 different concentrations of each drug (2.5 mM, 5 mM, 10 mM, 20 mM, 40 mM) were tested. 24 hpf dechorionated embryos were transferred to 6-well-plates and treated with the following drugs dissolved in E3 solution with 0.003% 1-pheny-2-thiourea (PTU, Alfa Aesar, Karlsruhe, Germany): penicillin G potassium salt (AppliChem, Darmstadt, Germany), ampicillin sodium salt (AppliChem, Darmstadt, Germany), gentamicin sulfate (Sigma-Aldrich, St. Louis, USA), kanamycin sulfate (AppliChem, Darmstadt, Germany), captopril (CalBiochem, Darmstadt, Germany), losartan potassium salt (Molekula, Gillingham, Dorset, United Kingdom), acetaminophen (Caesar und Loretz, Hilden, Germany), indomethacin sodium salt (AppliChem, Darmstadt, Germany). Treatment period was 24 hours. For indomethacin, lower concentrations (0.01 mM, 0.025 mM, 0.05 mM, 0.075 mM and 0.1 mM) had to be applied due to 100% lethality rates at higher concentrations. 2-4 repeats of each experiment were performed. Total number of embryos that underwent drug treatment is shown in Table S1. The pH was adjusted for each experiment. Following drug treatment, the number of dead larvae was assessed and the living larvae were transferred to 0.003% PTU containing E3 solution. For imaging studies, 0.03% tricaine was added to the medium.

Morpholino injections

Antisense splice blocking morpholino oligonucleotides (Gene Tools, LLC, Philomath, USA) were designed against the exon1-intron1 and exon2 –intron2 boundary of zebrafish ift172 gene, and ift80 morpholino has been previously published [23]. Morpholinos were injected into 1-cell stage embryos at 500 nM concentration. Both ift172 morpholinos resulted in similar phenotypes comparable to the phenotype previously published [24,2526]. A standard control oligonucleotide was used as control. Morpholino sequences: ift80 splice blocking MO: 5’-AGGTGTATGTGGAACCTGTGATAAG-3’, ift172 Exon2 splice donor blocking MO: 5’-ACGAGATGAGAGCTTACTTTTGGGT-3’, ift172 Exon1 splice blocking MO: 5’-ACGCTGTCAATATTTTACCTGAGGC-3’, Standard control (ctr) oligonucleotide: 5’-CCTCTTACCTCAGTTACAATTTATA-3’.

Generation of a 96 well template tool

The tool is made from brass and consists of a base plate with 96 perpendicular pins arranged in a certain way to match the positions of the wells of a microtiter plate. The tool was produced by CNC milling (Datron, M7). In a first step, the base plate with the dimensions of 140 mm x 100 mm x 21 mm was milled by a four flute end mill (20 mm). Secondly, the array of 96 pins with 11 mm height and rectangular footprint (5.9 mm x 1 mm) was created by partly thinning the base plate down to 9 mm between the pins (Four Flute End Mill, 6 mm and 3 mm, respectively). Finally, the ends of the 96 pins were tapered to a conical tip with 60° by utilizing a standard engraving tool.

Preparation of agarose molds in microtiter plates

70 µl of 1% agarose in fish water was added to each well of a 96 well microtiter plate (Cat.-No. 655180, Greiner, Frickenhausen, Germany) using a multi-channel pipette. The agarose coated well plates were pre-cooled at room temperature for one minute. To generate grooves the brass tool was inserted, while adjusting the penetration depth of pins using spacers. After solidification the tool was carefully removed and plates were optionally stored in plastic bags at 4°C. Embryos were transferred in 100 µl fish water containing PTU and tricaine (see above) and manually arrayed and oriented under a stereomicroscope. To aid in positioning of regions of interest within the grid-based and fixed field views of the Scan^R system, embryos were positioned in such a way that all yolk sacs were approximately at the same position within cavities using features of the well plate as guidelines.

Image acquisition

Embryos were imaged on a standard Scan^R high-content screening microscope (Olympus, Hamburg, Germany) [27] as previously described [16,22]. Data was acquired using 33 z-slices (Δz = 15μm) per embryo and channel using a 4x (N.A. = 0.13) objective. Integration times were fixed (80 ms for GFP). Imaging times were approximately 1 hour for a full 96 well plate. For each experimental plate the A1 positions of the imaging grid was re-centered to compensate for minor differences in positioning of embryos.

Data handling, deconvolution and visualization

Data handling, generation of multilayer tiffs and generation of maximum projections were carried out using custom written Perl scripts and Fiji [28] macros available on request. Fluorescence z-stacks were deconvolved with Huygens Professional deconvolution software (SVI, Hilversum, The Netherlands) using a theoretical point spread function based on microscope parameters. Batch deconvolution was carried out on a workstation with 24 CPU cores and 64 Gigabyte of memory. Cropping of images and generation of overview images was carried out using a Fiji macro (Macro S1). In brief, maximum projection images were duplicated, automatically thresholded and the resulting binary images were eroded. The position of kidneys was detected by measuring the center of mass. The corresponding coordinates were restored on original images, a bounding box was defined and images were cropped accordingly. Cropped images were loaded into a stack and overview images were generated using the ‘Make Montage’ function of Fiji.

Analysis of morphological and pronephric phenotypes

Overall morphology was scored on a Leica MZ10 F stereomicroscope (Leica Microsystems, Wetzlar, Germany). Lethality and pericardial/yolk sac edema were rated for each experiment. Blinded analysis of tubular and glomerular phenotypes was performed by SS and JHW on maximum projections of deconvolved z-stacks. Using ImageJ, 2 parameters were manually measured for tubular structures: i) maximum distance between the tubules and ii) angle between neck segment and proximal convoluted tubule [18] being visible in Tg(wt1b:EGFP) zebrafish. For description of glomerular changes, the distance between the glomeruli was determined and glomeruli were classified as either normal or showing glomerular malformation judged by the glomerular area and structure. Heatmaps were generated using matrix2png [29].

Histological analysis

Larvae were fixed in 4% paraformaldehyde overnight at 4°C. Samples were dehydrated through an ethanol series and processed for embedding in Paraffin (Surgipath® Paraplast®, Leica Biosystems, Wetzlar, Germany). 3 μm sections were cut using a Leica RM 2165 microtome (Leica Microsystems, Nussloch, Germany). Sections were deparaffinized in xylene and rehydrated through graded washes of ethanol in water before staining with hematoxylin and eosin. The stained sections were imaged with a Leica DMI4000 B microscope equipped with a Leica DFC320 digital camera.

Statistical analysis

Data were evaluated using IBM® SPSS® Statistics Version 21. For lethality and edema rates and glomerular fusion and malformation, statistical analysis was performed by Chi-square test. Datasets of low sample sizes were additionally tested using Fisher’s exact test. For tubular angle and distance, means among treatment groups were compared using ANOVA with Bonferroni correction for multiple comparisons as a post-hoc test. Significance was defined as p<0.05.

Results and Discussion

Standard positioning of embryos for chemical screening

The visualization of bilateral symmetric organs of zebrafish embryos usually demands dorsal or ventral views. However, consistent large scale imaging of zebrafish embryos remains challenging in automated screening experiments, as stable and reproducible positioning is complicated by the size and complex three-dimensional shape of embryos.

To enable a simplified handling and precise positioning of zebrafish larvae and to achieve consistent visualization of tissues in high content screening scenarios, we have developed a tool to create agarose molds in a standard microtiter plate. The tool allows the preparation of agarose coated 96 well plates in a single replication step. The tool consists of a base plate with 96 rectangular pins, whose positions exactly match the centers of wells of standard and commercially available 96 well microtiter plates (Figure 1A, B). The pins end with a keel shaped geometry, which was previously shown to be suitable for accurate ventral positioning of zebrafish larvae [16]. The tool was fabricated out of a solid block of brass using CNC milling (Figure 1A, B), giving rise to a precise work piece with identical xyz-dimensions of each pin allowing the generation of deep keel-shaped cavities in wells of a 96-well plate filled with agarose (Figure 1C). Such prepared plates can be readily used to manually position specimen enabling the subsequent automated acquisition of dorsal views using inverted screening microscope systems (Figure 1D).

Figure 1
Standardized orientation of zebrafish embryos.

We recently demonstrated an alternative protocol for automated dorsal imaging of oriented larvae using a silicone tool to generate an array of 96 agarose molds [16]. However, while plates generated with this tool can be employed for the consistent automated imaging of tissues, the design prevents utilization in chemical or drug screening applications. The novel device allows generation of molds in each well independently, thus avoiding cross-contamination, which was a major limitation of the previous design. Furthermore, the restriction to single wells and the depths of the cavities drastically minimizes movement of surrounding medium leading to a massively improved stability of orientation of embryos in comparison to the silicone template. Thus, plates with oriented embryos and larvae could be used in combination with automated plate handling and stacking systems.

Pipeline for automated pronephros imaging

To visualize and score renal phenotypes, we developed a protocol for automated imaging of dorsal views of zebrafish larval kidneys (Figure 2A). Prior to imaging, compound treated or microinjected embryos of the Tg(wt1b:EGFP) stable transgenic line were raised to the desired developmental stage (48 or 72 hpf) and then transferred into microtiter plates containing agarose cavities as described above (Figure 2B, C). To automatically image zebrafish kidneys, larvae were manually positioned and oriented in the agarose cavities and subsequently imaged on a standard widefield HCS microscope. To ensure capture of entire organs and compensate for minor variations in z-positioning, each larva was acquired using z-stacks with 33 slices in the bright field and GFP channel (Figure 2D). The cavities in the plate allow larvae to be positioned with high enough accuracy, so that regions of interest (e.g. pronephros) are located within the limited field of view for all plated embryos. Thus, the tool permits the organ and tissue specific screening on standard screening microscopes using a fixed field of view for all wells, without the necessity of additional software modules for automatic detection and centering the region of interests [16].

Figure 2
Overview of workflow for the automated imaging of the developing zebrafish pronephros.

The screening system used in this study stores data as single tiff files in one folder per experimental plate. To reduce file number and thus facilitate subsequent data handling and analysis tasks, multilayer tiff files were generated for each imaging position and channel. Spatial widefield data usually suffers from out-of-focus blur thus reducing overall image quality [30]. To restore images, fluorescent datasets were batch deconvolved with Huygens Professional software using a theoretical point spread function [16]. Subsequently, maximum projection images were generated from deconvolved z-stacks (Figure 2E). The positions of larval kidneys were automatically detected within maximum projections of deconvolved data using the center of mass of the corresponding binary image after automatic thresholding. To restrict image data to the pronephric region and remove unnecessary areas, a bounding box was defined around the center of mass and images were cropped accordingly (Figure 2F). Subsequently, overview images were generated from cropped kidney images representing all kidneys in one 96-well plate, allowing for rapid manual assessment of morphological phenotypes (Figure 2G). In summary, this pipeline allows consistent imaging and rapid evaluation of gross morphological abnormalities of the developing zebrafish kidney after compound treatment or in genetic screens. It can also be easily adapted for the analysis of other tissues and organs that require consistent imaging.

A pilot screen for drug-related effects on kidney development

The pipeline was subsequently evaluated in a pilot screen to investigate the impact of potentially nephrotoxic drugs on the development of the zebrafish pronephros. To this end, a subset of drugs from different classes was chosen for which an adverse effect on the developing kidney was previously identified in animal studies and/or human observations [2]. Dechorionated 24 hpf old embryos were treated with 8 different drugs in increasing concentrations for 24 hours. Following drug treatment, live larvae were imaged and data was visualized as described above.

To score lethality rates and development of pericardial and yolk sac edema, treated larvae were examined on a stereo microscope. The detailed results are listed in Table S1.

To objectively quantify morphological abnormalities of the pronephros following drug treatment, glomerular and tubular alterations were discriminated in the Tg(wt1b:EGFP) transgenic line. Glomerular alterations were subdivided into (i.) glomerular malformation indicated by abnormal or reduced glomerular shape and area, and (ii.) incomplete glomerular fusion representing aberrant pronephros development. Tubular parameters were classified into (i.) the angle between the tubular neck segment and the proximal convoluted tubule and (ii.) variations in the maximum distance between the 2 tubular systems (Figure 3A). Several drugs showed concentration dependent effects on overall survival rates, edema formation and pronephric phenotypes. Detailed results are listed in Table S1-S3. Color coded overview maps were also generated (Figure 3I-M). To validate phenotypic alterations observed in the transgenic model and thus confirm the utility of the proposed screening pipeline, histological analysis of glomerular and tubular cross-sections of 48 hpf larvae treated at the highest non-lethal concentration was carried out (Figure S1).

Figure 3
Overview of compound concentration-dependent pronephric phenotypes.

Impact of tested compounds on kidney development

In humans, due to the putative absence of fetal toxicity at therapeutic doses, penicillin antibiotics are widely prescribed to pregnant women and frequently administered to preterm newborns [31]. In our study, penicillin G potassium salt administration increased lethality rates dose-dependently (Figure 3I). Concomitantly, minor pronephric alterations were observed including incompletely fused glomeruli (Figure 3B). On the other hand, ampicillin sodium salt did not cause higher lethality, increased edema rates or major phenotypic renal alterations (Figure 3C, I-M). Cross-sections of larvae treated with penicillin G or ampicillin did not show major glomerular or tubular alterations when compared to untreated control larvae (Figure S1A-C), thus confirming results obtained by fluorescence microscopy. Taken together, this indicates only minor effects of the 2 β-lactam antibiotics on pronephros development.

Aminoglycosides, although not recommended during pregnancy [31], are often used for treatment of neonatal sepsis, even in premature newborns with on-going nephrogenesis. However, serum drug concentrations can be monitored to minimize the risk of renal and auditory toxicity [32]. In our study, gentamicin sulfate administration caused only a minor increase in lethality rates without significant effects on edema formation (Figure 3I, J). Nevertheless, glomerular malformation and incomplete glomerular fusion were found for higher drug concentrations. Tubular angle was slightly widened at higher doses (Figure 3D, M). Histological analysis of gentamicin-treated larvae revealed no gross morphological abnormalities, although a mild rarefication of capillary loops could be seen (Figure S1D). Kanamycin caused a concentration-dependent increase in lethality and edema formation (Figure 3I, J). However, glomerular and tubular parameters remained unaltered (Figure 3E). Concordantly, no major glomerular or tubular alterations were observed in histological sections of larvae following kanamycin administration (Figure S1E). In other studies, microinjection of gentamicin into the cardiac venous sinus led to acute renal failure [33]. As only minor effects of gentamicin were observed in our study, it suggests that this may have been due to poorer penetration into inner organs. Several human and animal studies report on aminoglycoside-induced glomerular and tubular damage in pre- and at-term newborns [34,3536]. Substance-specific differences in the degree of ototoxic and nephrotoxic side effects among various aminoglycosides are well known [37].

In humans, the intake of acetaminophen at therapeutic doses during gestation and administration to preterm newborns has been considered safe [38]. Its hepatotoxicity at high doses is well described [39] and has recently been investigated in zebrafish [40]. In addition, animal data further revealed fetal kidney damage following acetaminophen administration to pregnant rats [41]. In our study, acetaminophen caused concentration dependent significant alterations of pronephros morphology and an increase in edema formation, whereas lethality rates remained unchanged (Figure 3F, I-M). Histological sections confirmed severe renal phenotypes following acetaminophen administration. No fused glomerulus was detectable ventrally to the dorsal aorta and glomerular structures appeared strongly malformed. In addition, tubular epithelium was flattened (Figure S1F). These results match previously published data showing dose-, duration- and onset-dependent changes in pronephros morphology following acetaminophen administration in zebrafish larvae [42].

Intake of ACE inhibitors and angiotensin receptor blockers during pregnancy has been associated with fetopathies including renal pathologies in humans [43,4445] and other mammals [46]. In our study, captopril at 40 mM significantly increased edema formation and induced concentration dependent alterations in glomerular and tubular parameters (Figure 3G, I-M). Losartan increased lethality rates and glomerular and tubular parameters at higher concentrations, while edema rates were unchanged (Figure 3H, I-M). Additionally, captopril and losartan treated larvae displayed slightly altered glomerular structure in histological sections that appeared less dense compared to controls (Figure S1G, H).This data is partially consistent with animal studies showing renal abnormalities after treatment with ACE inhibitors or angiotensin receptors [47,4849].

NSAIDs are widely used for closure of patent ductus arteriosus in preterms and are administered during pregnancy for prevention and treatment of toxemia, polyhydramnions and premature birth. However, exposure to NSAIDs during pregnancy can cause hypoperfusion of the fetal kidneys and acute renal failure in newborns with cystic changes of developing nephrons and long-term renal dysfunction [2,50]. In our study, concentrations of the non-selective COX1/COX2 inhibitor indomethacin had to be lowered due to 100% lethality at higher doses. Strikingly, even at drastically lower concentrations there was a severe phenotype (Figure 4A-E). This included concentration dependent increases in edema formation and lethality (Figure 4D, F). Fluorescence microscopy (Figure 4A, E) revealed significant concentration dependent increases in glomerular malformation and incomplete glomerular fusion (Figure 4G). Furthermore, tubular angles widened and tubular distances slightly shortened (Figure 4H). Severe renal phenotypes were also confirmed in histological sections of indomethacin treated larvae. Here, no regular glomerulus was detectable ventrally to the dorsal aorta and laterally seen glomerular structures appeared strongly malformed or were not identifiable. Additionally, pronephric tubular epithelium appeared flattened (Figure S1I). Thus, our data in larval zebrafish matches previously published data from other animal models confirming severe renal side effects of indomethacin on kidney development during nephrogenesis [50].

Figure 4
Impairment of pronephros development upon indomethacin treatment.

Automated microscopy screening of genetic kidney disease models

Beyond performing toxicological screens for kidney damage, the presented automated microscopy pipeline can be utilized in the analysis of genetic disease models. Gene-knockdown or knock-out models can potentially be used for HCS investigations for the search of therapeutic strategies for hereditary kidney diseases. To test the utility of the developed pipeline, we focused on cilia-associated human genetic disorders.

Intraflagellar transport (IFT) constitutes the bidirectional transport of protein complexes along axonemal microtubules. IFT plays an essential role in the assembly and function of cilia and flagella by contributing to cell motility, sensory perception and cilium-based signaling [51,52]. IFT80 and IFT172 both are members of the IFT-B subcomplex [53] and while IFT80 mutations in humans have been identified to cause Jeune asphyxiating thoracic dystrophy [23], a congenital ciliary chondrodysplasia condition associated with renal disease in approximately 20% of cases [54], no human mutations in IFT172 have been identified to date. However, abrogation of Ift172 function in mice leads to a VACTERL-like phenotype including renal malformations [55], indicating that IFT172 plays an important role for kidney development in mammals. In zebrafish, the insertional mutant line ift172hi2211Tg exhibits glomerular cysts and a ventral body curvature [56].

Splice blocking morpholinos for ift80 and ift172 were designed as described in the Methods section. By using the standard positioning tool as described above, automated imaging of dorsally positioned morpholino-injected Tg(wt1b:EGFP) zebrafish (3 dpf) was performed in 96 well plates (Figure 5A). Microscopy revealed a ventral curvature of the tail (Figure 5B-D) affecting approximately 90% of all morpholino injected embryos and consistent with the phenotype previously described for ift80 morphants [23]. Morphological alterations in fluorescence microscopy predominantly consisted of large cystic glomeruli (Figure 5E-G) that were consistently reproducible [23], while embryos treated with standard morpholino showed normal glomerular morphology. Cross-sections of both ift80- and ift172-morpholino injected Tg(wt1b:EGFP) zebrafish confirmed the formation of large pronephric cysts (Figure S2A-C). Tubular dilatation and epithelial flattening was observed both in fluorescence images (Figure 5F, G) and histological sections (Figure S2B, C). This further demonstrates that our pipeline is suitable for large scale therapeutic screening investigations in genetic models of renal disease such as ciliopathies. However, the applicability largely depends on the morphological phenotypes as severe malformations impair position accuracy within cavities.

Figure 5
Detection of cystic kidneys after Ift80 and Ift172 knockdown.


Here, we demonstrate the development of an automated screening pipeline for imaging developing kidneys in the zebrafish larvae. This novel methodology allows for the consistent acquisition of dorsal views of pronephric kidneys on a standard inverted screening microscope. The platform can serve as a convenient tool in kidney research, e.g. in chemical studies as a primary screening tool to identify organotoxic substances or to search for potential therapeutic compounds that attenuate renal pathology in disease models. Importantly, the imaging protocol is easy-to-use and can be readily modified for studying other organ systems or tissues such as the brain region. Furthermore, in combination with HCS software tools which enable automated feature of interest detection, it can be used for the automated acquisition of standardized multidimensional high resolution datasets.

The pilot screen for nephrotoxic drugs during nephrogenesis revealed a concentration dependent effect of several compounds on nephrogenesis. Thus, considering the lingering lack of data for many substances, subsequent large-scale investigations performed with this screening pipeline might contribute to our understanding of substance-specific nephrotoxic side effects.

The current pipeline only allows for scoring of gross morphological abnormalities of the pronephros. Therefore, we validated the impact of treatments on pronephros formation by histological analysis, which largely confirmed the phenotypes observed in the transgenic model. This further demonstrates the utility of the established screening pipeline to score pronephric phenotypes. Moreover, the histological analysis revealed additional alterations, such as epithelial flattening, which are more difficult to score in the fluorescence data, thus complementing the in vivo approach. Although protocols for large scale histology experiments exist [57], the fast filtering of compound libraries by in vivo screening is considerably more time- and cost effective. Therefore, we propose that in a genuine large scale experiment, histological analysis is only carried out as a follow-up experiment in combination with molecular methods to characterize hits identified in a screen.

The mode of drug administration imposes another limitation of the established pipeline, as penetration to inner organs can be hampered by the chemical and physical properties of the noxa and the biological barrier of the larval zebrafish skin. This can be overcome by microinjection of drugs into the blood stream as described by Hentschel et al. [33]. Duration of drug treatment and its transferability to the human situation is another limitation of the pilot screen in zebrafish. In zebrafish, glomerular filtration starts around 48 hpf and the pronephros is fully matured at 4 dpf [58]. Hence, due to the rapid embryogenesis of the zebrafish, future studies have to employ different treatment periods to analyze the impact of compounds at the different stages of nephrogenesis [42].

Genetic research over the last years has demonstrated that the zebrafish pronephros is a valuable model system for the study of hereditary human nephropathies as abnormalities in podocyte gene function, renal epithelial primary cilia genes and renal ion channels and transporters lead to defective pronephric kidney function in the zebrafish mimicking human disease [59]. However, screening for disease modulating compounds in a zebrafish model requires convenient and accessible protocols. Here, we demonstrate that the developed imaging pipeline can also be utilized to detect abnormal phenotypes in genetic disease models. Thus, it could serve as a platform for prospective high-content drug screening experiments.

Finally, for genuine high content screening, an automated image analysis pipeline for extracted morphological features would be highly beneficial [22,60]. Moreover, compounds influencing kidney function without altering pronephros morphology cannot be identified using this pipeline. Thus, protocols for the large scale analysis of kidney function need to be developed or modified to be compatible with automated imaging assays, respectively [61].

Supporting Information

Figure S1

Cross-sections of pronephric regions after compound exposure. Shown are glomerular (upper panels) and tubular (lower panels) sections at 48 hours post fertilization. (A) control, (B) penicillin (20 mM), (C) ampicillin (40 mM), (D) gentamicin (40 mM), (E) kanamycin (40 mM), (F) acetaminophen (40 mM), (G) captopril (40 mM), (H) losartan (10 mM) and (I) indomethacin (0.75 mM) treatment.


Figure S2

Cross-sections of pronephric regions after morpholino injections. Shown are glomerular (upper panels) and tubular (lower panels) sections at 72 hours post fertilization. (A) control-MO, (B) ift80-MO and (C) ift172-MO injection.


Table S1

Lethality and edema formation in zebrafish larvae following drug treatment.


Table S2

Glomerular alterations in zebrafish larvae following drug treatment.


Table S3

Tubular angle and distance in zebrafish larvae following drug treatment.


Macro S1

Fiji macro to crop images and generate overview images.



We thank Sebastian Hötzel for fish care, J. Bohn for CNC milling, B. Rodenbeck for technical assistance and Dr Christoph Englert (Leibniz Institute for Age Research-Fritz Lipmann Institute, Jena, Germany) for kindly providing the Tg(wt1b:EGFP) transgenic line. We are grateful to Dr Jens Fahrenberg (Innovation Department, Karlsruhe Institute of Technology, Germany) for general support. We thank Sundeep Dhillon for critically reading the manuscript.

Funding Statement

This project was supported by the European Commission Seventh Framework Programme funded projects DOPAMINET (http://www.dopaminet.eu/; grant no. 223744) and Eurenomics (http://www.eurenomics.eu/; grant no. 305608) to UL, and SYSCILIA (http://www.syscilia.org/; grant no. 241955) to PLB, the Stiftung Landesbank Baden-Württemberg to JHW, the Dutch Kidney foundation (CP11.18) to PLB and MS and institutional funding from Innovation Department, Karlsruhe Institute of Technology (KIT), Germany. MS was funded by an Action Medical Research UK clinical training fellowship (RTF-1411) and PLB is a Wellcome Trust Senior Research Fellow. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. De Vigan C, De Walle HE, Cordier S, Goujard J, Knill-Jones R et al. (1999) Therapeutic drug use during pregnancy: a comparison in four European countries. OECM Working Group. Occupational Exposures and Congenital Anomalies. J Clin Epidemiol 52: 977-982.10.1016/S0895-4356(99)00091-8 PubMed: 10513761 [PubMed]
2. Zaffanello M, Bassareo PP, Cataldi L, Antonucci R, Biban P et al. (2010) Long-term effects of neonatal drugs on the kidney. J Matern Fetal Neonatal Med 23Suppl 3: 87-89.10.3109/14767058.2010.501156 PubMed: 20653340 [PubMed]
3. U.S. Department of Health and Human Services NIoH (National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)) Overview of Kidney Diseases in Children. Available: http://kidney.niddk.nih.gov/kudiseases/pubs/childkidneydiseases/overview/ pp. NIH Publication No. 06–5167 June 2006
4. McCollum CW, Ducharme NA, Bondesson M, Gustafsson JA (2011) Developmental toxicity screening in zebrafish. Birth Defects Res C Embryo Today 93: 67-114.10.1002/bdrc.20210 PubMed: 21671351 [PubMed]
5. Knudsen TB, Kavlock RJ, Daston GP, Stedman D, Hixon M et al. (2011) Developmental toxicity testing for safety assessment: new approaches and technologies. Birth Defects Res B Dev Reprod Toxicol 92: 413-420.10.1002/bdrb.20315 PubMed: 21770025 [PubMed]
6. Pepperkok R, Ellenberg J (2006) High-throughput fluorescence microscopy for systems biology. Nat Rev Mol Cell Biol 7: 690-696.10.1038/nrm1979 PubMed: 16850035 [PubMed]
7. Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4: 35-44.10.1038/nrd1606 PubMed: 15688071 [PubMed]
8. Lessman CA (2011) The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries. Birth Defects Res C Embryo Today 93: 268-280.10.1002/bdrc.20212 PubMed: 21932435 [PubMed]
9. Rihel J, Schier AF (2012) Behavioral screening for neuroactive drugs in zebrafish. Dev Neurobiol 72: 373-385.10.1002/dneu.20910 PubMed: 21567979 [PubMed]
10. Tan JL, Zon LI (2011) Chemical screening in zebrafish for novel biological and therapeutic discovery. Methods Cell Biol 105: 493-516 PubMed: 21951544 [PubMed]
11. Yang L, Ho NY, Alshut R, Legradi J, Weiss C et al. (2009) Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod Toxicol 28: 245-253.10.1016/j.reprotox.2009.04.013 PubMed: 19406227 [PubMed]
12. d’Alençon CA, Peña OA, Wittmann C, Gallardo VE, Jones RA et al. (2010) A high-throughput chemically induced inflammation assay in zebrafish. BMC Biol 8: 151.10.1186/1741-7007-8-151 PubMed: 21176202 [PMC free article] [PubMed]
13. Evensen L, Link W, Lorens JB (2010) Imaged-based high-throughput screening for anti-angiogenic drug discovery. Curr Pharm Des 16: 3958-3963.10.2174/138161210794455030 PubMed: 21158729 [PubMed]
14. Kokel D, Bryan J, Laggner C, White R, Cheung CY et al. (2010) Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 6: 231-237.10.1038/nchembio.307 PubMed: 20081854 [PMC free article] [PubMed]
15. Pardo-Martin C, Chang TY, Koo BK, Gilleland CL, Wasserman SC et al. (2010) High-throughput in vivo vertebrate screening. Nat Methods 7: 634-636.10.1038/nmeth.1481 PubMed: 20639868 [PMC free article] [PubMed]
16. Peravali R, Gehrig J, Giselbrecht S, Lütjohann DS, Hadzhiev Y et al. (2011) Automated feature detection and imaging for high-resolution screening of zebrafish embryos. BioTechniques 50: 319-324 PubMed: 21548893 [PubMed]
17. Drummond IA (2005) Kidney development and disease in the zebrafish. J Am Soc Nephrol 16: 299-304.10.1681/ASN.2004090754 PubMed: 15647335 [PubMed]
18. Drummond IA, Davidson AJ (2010) Zebrafish kidney development. Methods Cell Biol 100: 233-260.10.1016/B978-0-12-384892-5.00009-8 PubMed: 21111220 [PubMed]
19. Perner B, Englert C, Bollig F (2007) The Wilms tumor genes wt1a and wt1b control different steps during formation of the zebrafish pronephros. Dev Biol 309: 87-96.10.1016/j.ydbio.2007.06.022 PubMed: 17651719 [PubMed]
20. Westerfield M (2000) The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio), 4th edition. University of Oregon Press, Eugene, OR
21. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310.10.1002/aja.1002030302 PubMed: 8589427 [PubMed]
22. Gehrig J, Reischl M, Kalmár E, Ferg M, Hadzhiev Y et al. (2009) Automated high-throughput mapping of promoter-enhancer interactions in zebrafish embryos. Nat Methods 6: 911-916.10.1038/nmeth.1396 PubMed: 19898487 [PubMed]
23. Beales PL, Bland E, Tobin JL, Bacchelli C, Tuysuz B et al. (2007) IFT80, which encodes a conserved intraflagellar transport protein, is mutated in Jeune asphyxiating thoracic dystrophy. Nat Genet 39: 727-729.10.1038/ng2038 PubMed: 17468754 [PubMed]
24. Cao Y, Semanchik N, Lee SH, Somlo S, Barbano PE et al. (2009) Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc Natl Acad Sci U S A 106: 21819-21824.10.1073/pnas.0911987106 PubMed: 19966229 [PMC free article] [PubMed]
25. Lunt SC, Haynes T, Perkins BD (2009) Zebrafish ift57, ift88, and ift172 intraflagellar transport mutants disrupt cilia but do not affect hedgehog signaling. Dev Dyn 238: 1744-1759.10.1002/dvdy.21999 PubMed: 19517571 [PMC free article] [PubMed]
26. Sukumaran S, Perkins BD (2009) Early defects in photoreceptor outer segment morphogenesis in zebrafish ift57, ift88 and ift172 Intraflagellar Transport mutants. Vision Res 49: 479-489.10.1016/j.visres.2008.12.009 PubMed: 19136023 [PMC free article] [PubMed]
27. Liebel U, Starkuviene V, Erfle H, Simpson JC, Poustka A et al. (2003) A microscope-based screening platform for large-scale functional protein analysis in intact cells. FEBS Lett 554: 394-398.10.1016/S0014-5793(03)01197-9 PubMed: 14623100 [PubMed]
28. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M et al. (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9: 676-682.10.1038/nmeth.2019 PubMed: 22743772 [PMC free article] [PubMed]
29. Pavlidis P, Noble WS (2003) Matrix2png: a utility for visualizing matrix data. Bioinformatics 19: 295-296 [PubMed]
30. Swedlow JR, Platani M (2002) Live cell imaging using wide-field microscopy and deconvolution. Cell Struct Funct 27: 335-341.10.1247/csf.27.335 PubMed: 12502887 [PubMed]
31. Mylonas I (2011) Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. Arch Gynecol Obstet 283: 7-18.10.1007/s00404-010-1646-3 PubMed: 20814687 [PubMed]
32. Rao SC, Srinivasjois R, Hagan R, Ahmed M (2011) One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev: CD: 005091 [PubMed]
33. Hentschel DM, Park KM, Cilenti L, Zervos AS, Drummond I et al. (2005) Acute renal failure in zebrafish: a novel system to study a complex disease. Am J Physiol Renal Physiol 288: F923-F929.10.1152/ajprenal.00386.2004 PubMed: 15625083 [PubMed]
34. McWilliam SJ, Antoine DJ, Sabbisetti V, Turner MA, Farragher T et al. (2012) Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study. PLOS ONE 7: e43809.10.1371/journal.pone.0043809 PubMed: 22937100 [PMC free article] [PubMed]
35. Kent AL, Maxwell LE, Koina ME, Falk MC, Willenborg D et al. (2007) Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatr Res 62: 307-312.10.1203/PDR.0b013e318123f6e3 PubMed: 17622959 [PubMed]
36. Martínez-Salgado C, López-Hernández FJ, López-Novoa JM (2007) Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol 223: 86-98.10.1016/j.taap.2007.05.004 PubMed: 17602717 [PubMed]
37. Sweileh WM (2009) A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function. Fundam Clin Pharmacol 23: 515-520.10.1111/j.1472-8206.2009.00702.x PubMed: 19709328 [PubMed]
38. Koren G, Pastuszak A, Ito S (1998) Drugs in pregnancy. N Engl J Med 338: 1128-1137.10.1056/NEJM199804163381607 PubMed: 9545362 [PubMed]
39. Jaeschke H, McGill MR, Ramachandran A (2012) Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 44: 88-106.10.3109/03602532.2011.602688 PubMed: 22229890 [PubMed]
40. North TE, Babu IR, Vedder LM, Lord AM, Wishnok JS et al. (2010) PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury. Proc Natl Acad Sci U S A 107: 17315-17320.10.1073/pnas.1008209107 PubMed: 20855591 [PMC free article] [PubMed]
41. Neto JA, Oliveira-Filho RM, Simões MJ, Soares JM Jr., Kulay L Jr. (2004) Long-term acetaminophen (paracetamol) treatment causes liver and kidney ultra-structural changes during rat pregnancy. Clin Exp Obstet Gynecol 31: 221-224 PubMed: 15491069 [PubMed]
42. Peng HC, Wang YH, Wen CC, Wang WH, Cheng CC et al. (2010) Nephrotoxicity assessments of acetaminophen during zebrafish embryogenesis. Comp Biochem Physiol C Toxicol Pharmacol 151: 480-486.10.1016/j.cbpc.2010.02.004 PubMed: 20170747 [PubMed]
43. Shrim A, Berger H, Kingdom J, Hamoudi A, Shah PS et al. (2005) Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible. Can Fam Physician 51: 1335-1337 PubMed: 16250418 [PMC free article] [PubMed]
44. Martinovic J, Benachi A, Laurent N, Daikha-Dahmane F, Gubler MC (2001) Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 358: 241-242.10.1016/S0140-6736(01)05426-5 PubMed: 11480433 [PubMed]
45. Pryde PG, Sedman AB, Nugent CE, Barr M Jr. (1993) Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3: 1575-1582 PubMed: 8507813 [PubMed]
46. Quan A (2006) Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 82: 23-28.10.1016/j.earlhumdev.2005.11.001 PubMed: 16427219 [PubMed]
47. Coleman CM, Minor JJ, Burt LE, Thornhill BA, Forbes MS et al. (2007) Angiotensin AT1-receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am J Physiol Renal Physiol 293: F262-F268.10.1152/ajprenal.00071.2007 PubMed: 17442727 [PubMed]
48. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H et al. (1994) Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45: 485-492.10.1038/ki.1994.63 PubMed: 8164437 [PubMed]
49. Loria A, Reverte V, Salazar F, Saez F, Llinas MT et al. (2007) Changes in renal hemodynamics and excretory function induced by a reduction of ANG II effects during renal development. Am J Physiol Regul Integr Comp Physiol 293: R695-R700.10.1152/ajpregu.00191.2007 PubMed: 17491111 [PubMed]
50. Drukker A (2002) The adverse renal effects of prostaglandin-synthesis inhibition in the fetus and the newborn. Paediatr Child Health 7: 538-543 PubMed: 20046466 [PMC free article] [PubMed]
51. Rosenbaum JL, Witman GB (2002) Intraflagellar transport. Nat Rev Mol Cell Biol 3: 813-825.10.1038/nrm952 PubMed: 12415299 [PubMed]
52. Scholey JM (2003) Intraflagellar transport. Annu Rev Cell Dev Biol 19: 423-443.10.1146/annurev.cellbio.19.111401.091318 PubMed: 14570576 [PubMed]
53. Ocbina PJ, Eggenschwiler JT, Moskowitz I, Anderson KV (2011) Complex interactions between genes controlling trafficking in primary cilia. Nat Genet 43: 547-553.10.1038/ng.832 PubMed: 21552265 [PMC free article] [PubMed]
54. de Vries J, Yntema JL, van Die CE, Crama N, Cornelissen EA et al. (2010) Jeune syndrome: description of 13 cases and a proposal for follow-up protocol. Eur J Pediatr 169: 77-88.10.1007/s00431-009-0991-3 PubMed: 19430947 [PMC free article] [PubMed]
55. Friedland-Little JM, Hoffmann AD, Ocbina PJ, Peterson MA, Bosman JD et al. (2011) A novel murine allele of Intraflagellar Transport Protein 172 causes a syndrome including VACTERL-like features with hydrocephalus. Hum Mol Genet 20: 3725-3737.10.1093/hmg/ddr241 PubMed: 21653639 [PMC free article] [PubMed]
56. Sun Z, Amsterdam A, Pazour GJ, Cole DG, Miller MS et al. (2004) A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 131: 4085-4093.10.1242/dev.01240 PubMed: 15269167 [PubMed]
57. Sabaliauskas NA, Foutz CA, Mest JR, Budgeon LR, Sidor AT et al. (2006) High-throughput zebrafish histology. Methods 39: 246-254.10.1016/j.ymeth.2006.03.001 PubMed: 16870470 [PubMed]
58. Kramer-Zucker AG, Wiessner S, Jensen AM, Drummond IA (2005) Organization of the pronephric filtration apparatus in zebrafish requires Nephrin, Podocin and the FERM domain protein Mosaic eyes. Dev Biol 285: 316-329.10.1016/j.ydbio.2005.06.038 PubMed: 16102746 [PMC free article] [PubMed]
59. Ebarasi L, Oddsson A, Hultenby K, Betsholtz C, Tryggvason K (2011) Zebrafish: a model system for the study of vertebrate renal development, function, and pathophysiology. Curr Opin Nephrol Hypertens 20: 416-424.10.1097/MNH.0b013e3283477797 PubMed: 21519251 [PubMed]
60. Vogt A, Cholewinski A, Shen X, Nelson SG, Lazo JS et al. (2009) Automated image-based phenotypic analysis in zebrafish embryos. Dev Dyn 238: 656-663.10.1002/dvdy.21892 PubMed: 19235725 [PMC free article] [PubMed]
61. Rider SA, Tucker CS, del-Pozo J, Rose KN, MacRae CA et al. (2012) Techniques for the in vivo assessment of cardio-renal function in zebrafish (Danio rerio) larvae. J Physiol 590: 1803-1809 PubMed: 22331420 [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...